Interesting point you raise about another (better) product in trials, might i say that in trials is different to being approved as i have said many times when referring to risks within msb. So can you provide any details on this to support that statement.
Funny how rather than ask this type of question the subsequent posts to yours just went for the jugular. Typical
Add to My Watchlist
What is My Watchlist?
